We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Visual Function After Implantation of AcrySof® Toric Lens

This study has been terminated.
(The study was terminated based on a business decision.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01074606
First Posted: February 24, 2010
Last Update Posted: September 19, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Alcon Research
  Purpose
The objective of this study is to evaluate the postoperative visual function of Taiwanese patients following bilateral or unilateral AcrySof Toric Intraocular Lens (IOL) implantation.

Condition Intervention Phase
Cataract Device: AcrySof Toric Intraocular Lens Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Alcon Research:

Primary Outcome Measures:
  • Postoperative Refractive Cylinder [ Time Frame: Pre-Operative Day, 1 Month Postoperative, 3 Month Postoperative ]

Secondary Outcome Measures:
  • Uncorrected distance visual acuity (UCDVA) [ Time Frame: Pre-Operative Day, 1 Month Postoperative, 3 Month Postoperative ]
  • Best corrected distance visual acuity (BDCVA) [ Time Frame: Pre-operative, 1 month postoperative, 3 months postoperative ]

Enrollment: 56
Study Start Date: January 2010
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Toric
AcrySof Toric Intraocular Lens (IOL)
Device: AcrySof Toric Intraocular Lens
Implantation of the AcrySof Toric Intraocular Lens (IOL)

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Prospective subjects should be adults and may be of any race and gender, and diagnosed with cataracts.
  • Subject must require extraction of cataracts followed by implantation of a posterior chamber intraocular lens.
  • All subjects must have between 0.75 - 2.0 Diopter (D) of astigmatism preoperatively as measured by keratometry readings.
  • For any second eye surgery in bilateral AcrySof Toric patients, it should be performed at least one week following the first eye implant but no longer than one month after the first implant.

Exclusion Criteria:

  • Subjects with pre-existing conditions that could skew the results should be excluded from the Study.
  • AcrySof® Toric product inserts under "Precautions" for subject groups that should be excluded from this Study.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01074606


Locations
Taiwan
Changhua City, Taiwan, 500
Sponsors and Collaborators
Alcon Research
  More Information

Responsible Party: Alcon Research
ClinicalTrials.gov Identifier: NCT01074606     History of Changes
Other Study ID Numbers: MT-0902
First Submitted: February 23, 2010
First Posted: February 24, 2010
Last Update Posted: September 19, 2012
Last Verified: August 2011

Keywords provided by Alcon Research:
Cataract

Additional relevant MeSH terms:
Cataract
Lens Diseases
Eye Diseases